UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 10, 2021
Oracle Corporation
(Exact name of registrant as specified in its charter)
Delaware
001-35992
54-2185193
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
2300 Oracle Way, Austin, Texas 78741
(Address of principal executive offices) (Zip Code)
(737) 867-1000
(Registrant s telephone number, including area code)
N/A
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange
on which registered
Common Stock, par value $0.01 per share
ORCL
New York Stock Exchange
3.125% senior notes due July 2025
ORCL
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ( 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Section 5 Corporate Governance and Management
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On November 10, 2021, at the 2021 Annual Meeting of Stockholders (the Annual Meeting ) of Oracle Corporation ( Oracle ), Oracle s stockholders approved an amendment to the Oracle Corporation 2020 Equity Incentive Plan (the 2020 Equity Plan ) to increase the number of shares of common stock reserved for issuance under the 2020 Equity Plan by 300,000,000 shares. Oracle s Board of Directors (the Board ) approved the amendment of the 2020 Equity Plan, subject to stockholder approval, on August 4, 2021.
The foregoing description of the 2020 Equity Plan is qualified in its entirety by reference to the 2020 Equity Plan, as amended, which is filed as Exhibit 10.16 to this report. A more complete description of the terms of the 2020 Equity Plan can be found in Proposal No. 3 Approval of an Amendment to the Oracle Corporation 2020 Equity Incentive Plan on pages 67 to 75 of Oracle s definitive proxy statement filed with the U.S. Securities and Exchange Commission on September 24, 2021 (the 2021 Proxy Statement ), which description is incorporated by reference herein.
Item 5.07
Submission of Matters to a Vote of Security Holders
Below is a brief description of each matter submitted to a vote at the Annual Meeting, as well as the number of votes cast for and against and the number of abstentions and broker non-votes with respect to each matter. For more information about these proposals, please refer to Oracle s 2021 Proxy Statement.
Proposal No. 1: Election of Directors
The stockholders elected each of the following persons as a director to hold office until the 2022 Annual Meeting of Stockholders and until his or her successor is elected and qualified, or until his or her earlier resignation or removal.
Director Nominee
Votes For
Votes Withheld
Broker Non-Votes
Jeffrey S. Berg
1,659,795,425
602,905,592
241,951,091
Michael J. Boskin
2,110,985,174
151,715,843
241,951,091
Safra A. Catz
2,162,731,887
99,969,130
241,951,091
Bruce R. Chizen
1,815,515,240
447,185,777
241,951,091
George H. Conrades
1,460,702,785
801,998,232
241,951,091
Lawrence J. Ellison
2,163,114,596
99,586,421
241,951,091
Rona A. Fairhead
2,224,874,586
37,826,431
241,951,091
Jeffrey O. Henley
2,175,596,476
87,104,541
241,951,091
Ren e J. James
2,195,024,169
67,676,848
241,951,091
Charles W. Moorman IV
1,565,169,470
697,531,547
241,951,091
Leon E. Panetta
1,474,712,503
787,988,514
241,951,091
William G. Parrett
1,908,379,449
354,321,568
241,951,091
Naomi O. Seligman
1,529,860,334
732,840,683
241,951,091
Vishal Sikka
2,122,816,004
139,885,013
241,951,091
Proposal No. 2: Advisory Vote to Approve the Compensation of Oracle s Named Executive Officers
The stockholders cast an advisory vote approving the compensation of Oracle s named executive officers as follows: 1,358,928,813 shares in favor, 900,029,544 shares against, 3,742,660 shares abstaining and 241,951,091 broker non-votes.
Proposal No. 3: Approval of an Amendment to the Oracle Corporation 2020 Equity Incentive Plan
The stockholders approved an amendment to the 2020 Equity Plan with 1,762,377,240 shares in favor, 494,314,379 shares against, 6,009,398 shares abstaining and 241,951,091 broker non-votes.
Proposal No. 4: Ratification of Selection of Independent Registered Public Accounting Firm
The stockholders ratified the appointment of Ernst & Young LLP as Oracle s independent registered public accounting firm for the fiscal year ending May 31, 2022, with 2,467,952,666 shares in favor, 34,066,688 shares against and 2,632,754 shares abstaining.
Proposal No. 5: Stockholder Proposal Regarding Racial Equity Audit
The stockholders did not approve a stockholder proposal requesting that Oracle s Board oversee a racial equity audit analyzing Oracle s impacts on non-white stakeholders and communities of color, with 715,611,230 shares in favor, 1,536,754,357 shares against, 10,335,430 shares abstaining and 241,951,091 broker non-votes.
Proposal No. 6: Stockholder Proposal Regarding Independent Board Chair
The stockholders did not approve a stockholder proposal requesting that Oracle s Board adopt a policy requiring the Chair of the Board, whenever possible, to be an independent member of the Board, with 803,808,786 shares in favor, 1,455,613,840 shares against, 3,278,391 shares abstaining and 241,951,091 broker non-votes.
Proposal No. 7: Stockholder Proposal Regarding Political Spending
The stockholders did not approve a stockholder proposal requesting that Oracle adopt a policy requiring any organization which engages in political activities that receives financial support from Oracle to report, at least annually, the organization s expenditures for political activities, with 120,648,279 shares in favor, 2,126,557,352 shares against, 15,495,386 shares abstaining and 241,951,091 broker non-votes.
Section 9 Financial Statements and Exhibits
Item 9.01
Financial Statements and Exhibits
(d) Exhibits
Exhibit
No.
Description
10.16
Oracle Corporation Amended and Restated 2020 Equity Incentive Plan (as approved by the stockholders on November 10, 2021)
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.